|
PWP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.460400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.114000E-01 |
| Normal-vs-Stage2 |
6.134800E-01 |
| Normal-vs-Stage3 |
5.680000E-01 |
| Normal-vs-Stage4 |
5.373800E-01 |
| Stage1-vs-Stage2 |
1.632000E-01 |
| Stage1-vs-Stage3 |
7.560000E-01 |
| Stage1-vs-Stage4 |
7.648800E-01 |
| Stage2-vs-Stage3 |
3.707000E-01 |
| Stage2-vs-Stage4 |
3.569600E-01 |
| Stage3-vs-Stage4 |
9.795400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.074000E-01 |
| Normal-vs-AfricanAmerican |
1.037710E-03 |
| Normal-vs-Asian |
5.911400E-01 |
| Caucasian-vs-AfricanAmerican |
9.61550000000422E-05 |
| Caucasian-vs-Asian |
7.670000E-01 |
| AfricanAmerican-vs-Asian |
2.809800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.159600E-01 |
| Normal-vs-Female |
3.359600E-02 |
| Male-vs-Female |
2.174100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.626200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.984370E-01 |
| Normal-vs-Age(61-80Yrs) |
5.492200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.165400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.944400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.554000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.423600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.810600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.497000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.675800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.964100E-04 |
| Normal-vs-Grade 2 |
2.435800E-01 |
| Normal-vs-Grade 3 |
7.587400E-01 |
| Normal-vs-Grade 4 |
6.381200E-01 |
| Grade 1-vs-Grade 2 |
2.391700E-02 |
| Grade 1-vs-Grade 3 |
4.506000E-02 |
| Grade 1-vs-Grade 4 |
4.211900E-02 |
| Grade 2-vs-Grade 3 |
4.362800E-01 |
| Grade 2-vs-Grade 4 |
7.115200E-01 |
| Grade 3-vs-Grade 4 |
8.308600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.898600E-01 |
| Normal-vs-ccB subtype |
8.924000E-01 |
| ccA subtype-vs-ccB subtype |
4.600600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.173200E-01 |
| Normal-vs-N1 |
3.680600E-01 |
| N0-vs-N1 |
3.132400E-01 |
|
|
